Chicago Partners Investment Group LLC

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 1563525 CHICAGO, IL

Position in TSHA

as of Mar 31, 2026 · filed May 4, 2026 Compact

Position Value

$763,256

-$152,719 QoQ

Shares Held

170,751

+2.5% QoQ

Ownership

0.059%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#72

of 190 holders

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 0.5335254259125861.ToString("F0")% Shared 0.ToString("F0")% None 99.46647457408741.ToString("F0")%

Healthcare · as of Mar 31, 2026

Chicago Partners Investment Group LLC holds $9,972,920 across 37 Biotechnology names. TSHA ranks #3 (7.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	2,001	$1,546,052
2	INCY	Incyte Corp	8,174	$769,336
3	TSHA	Taysha Gene Therapies, Inc. This page	170,751	$763,256
4	ASND	Ascendis Pharma A/S	3,054	$698,541
5	EXEL	Exelixis, Inc.	16,204	$694,989
6	BMRN	Biomarin Pharmaceutical Inc	12,183	$688,217
7	JAZZ	Jazz Pharmaceuticals plc	2,861	$540,872
8	VRTX	Vertex Pharmaceuticals Inc / Ma	1,170	$522,451

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$763,256	170,751	+2.5%	Shares	Sole	2026-05-04
2025-12-31	$915,975	166,541	+1.5%	Shares	Sole	2026-01-28
2025-09-30	$536,400	164,037	+0.2%	Shares	Sole	2025-10-30
2025-06-30	$378,299	163,766	+40.5%	Shares	Sole	2025-07-29
2025-03-31	$162,025	116,565	+0.4%	Shares	Sole	2025-05-09
2024-12-31	$200,756	116,044	-1.8%	Shares	Sole	2025-01-24
2024-09-30	$237,531	118,175	+1.1%	Shares	Sole	2024-10-29
2024-06-30	$261,867	116,905	-6.7%	Shares	Sole	2024-07-31
2024-03-31	$359,565	125,284	-7.1%	Shares	Sole	2024-04-25
2023-12-31	$238,686	134,851	+21.4%	Shares	Sole	2024-02-23
2023-09-30	$351,110	111,111	—	Shares	Sole	2023-10-26
No filing history on record for this holder in this stock.